{"id":"https://openalex.org/W1963994668","doi":"https://doi.org/10.2165/1153426-s0-000000000-00000","title":"Nicolau Syndrome Following Etanercept Administration","display_name":"Nicolau Syndrome Following Etanercept Administration","publication_year":2010,"publication_date":"2010-06-01","ids":{"openalex":"https://openalex.org/W1963994668","doi":"https://doi.org/10.2165/1153426-s0-000000000-00000","mag":"1963994668","pmid":"https://pubmed.ncbi.nlm.nih.gov/20586511"},"language":"en","primary_location":{"id":"doi:10.2165/1153426-s0-000000000-00000","doi":"https://doi.org/10.2165/1153426-s0-000000000-00000","is_oa":false,"landing_page_url":"https://doi.org/10.2165/1153426-s0-000000000-00000","pdf_url":null,"source":{"id":"https://openalex.org/S71020152","display_name":"American Journal of Clinical Dermatology","issn_l":"1175-0561","issn":["1175-0561","1179-1888"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Journal of Clinical Dermatology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5017034001","display_name":"Claudio Guarneri","orcid":"https://orcid.org/0000-0003-3918-8779","observed_orcids":["https://orcid.org/0000-0003-3918-8779"]},"institutions":[{"id":"https://openalex.org/I112862951","display_name":"University of Messina","ror":"https://ror.org/05ctdxz19","country_code":"IT","type":"education","lineage":["https://openalex.org/I112862951"]},{"id":"https://openalex.org/I4210139630","display_name":"Azienda Ospedaliera Universitaria Policlinico \"G. Martino\"","ror":"https://ror.org/03tf96d34","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210139630"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Claudio Guarneri","raw_affiliation_strings":["Department of Social Territorial Medicine, Section of Dermatology, University of Messina, Messina, Italy. cguarneri@unime.it","Department of Social Territorial Medicine, Section of Dermatology, University of Messina c/o Institute of Dermatology, Policlinico Universitario \u2018G Martino\u2019,, Messina, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Social Territorial Medicine, Section of Dermatology, University of Messina, Messina, Italy. cguarneri@unime.it","institution_ids":["https://openalex.org/I112862951"]},{"raw_affiliation_string":"Department of Social Territorial Medicine, Section of Dermatology, University of Messina c/o Institute of Dermatology, Policlinico Universitario \u2018G Martino\u2019,, Messina, Italy","institution_ids":["https://openalex.org/I112862951","https://openalex.org/I4210139630"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5068423643","display_name":"Giovanni Polimeni","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I112862951","display_name":"University of Messina","ror":"https://ror.org/05ctdxz19","country_code":"IT","type":"education","lineage":["https://openalex.org/I112862951"]},{"id":"https://openalex.org/I4210162269","display_name":"Centro Neurolesi Bonino Pulejo","ror":"https://ror.org/05tzq2c96","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4210162269"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Giovanni Polimeni","raw_affiliation_strings":["IRCSS Centro Neurolesi \u2018Bonino-Pulejo\u2019, University of Messina, Messina, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"IRCSS Centro Neurolesi \u2018Bonino-Pulejo\u2019, University of Messina, Messina, Italy","institution_ids":["https://openalex.org/I112862951","https://openalex.org/I4210162269"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5017034001"],"corresponding_institution_ids":["https://openalex.org/I112862951","https://openalex.org/I4210139630"],"apc_list":{"value":5590,"currency":"USD","value_usd":5590},"apc_paid":null,"fwci":2.6437,"has_fulltext":false,"cited_by_count":38,"citation_normalized_percentile":{"value":0.90159345,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"11","issue":null,"first_page":"51","last_page":"52"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T14126","display_name":"Intramuscular injections and effects","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2711","display_name":"Emergency Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T14126","display_name":"Intramuscular injections and effects","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2711","display_name":"Emergency Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12433","display_name":"Skin Diseases and Diabetes","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11117","display_name":"Drug-Induced Adverse Reactions","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/nicolau-syndrome","display_name":"Nicolau syndrome","score":0.9990000128746033},{"id":"https://openalex.org/keywords/embolia-cutis-medicamentosa","display_name":"embolia cutis medicamentosa","score":0.9929999709129333},{"id":"https://openalex.org/keywords/etanercept","display_name":"etanercept","score":0.9950000047683716},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.8579999804496765},{"id":"https://openalex.org/keywords/subcutaneous-injection","display_name":"subcutaneous injection","score":0.8309999704360962},{"id":"https://openalex.org/keywords/tumor-necrosis-factor-inhibitors","display_name":"tumor necrosis factor inhibitors","score":0.8389999866485596},{"id":"https://openalex.org/keywords/psoriasis","display_name":"psoriasis","score":0.7419999837875366},{"id":"https://openalex.org/keywords/psoriatic-arthritis","display_name":"psoriatic arthritis","score":1.0},{"id":"https://openalex.org/keywords/injection-site-reactions","display_name":"injection site reactions","score":0.6330000162124634},{"id":"https://openalex.org/keywords/biological-agents","display_name":"biological agents","score":0.8240000009536743}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9473998546600342},{"id":"https://openalex.org/C2777226972","wikidata":"https://www.wikidata.org/wiki/Q415343","display_name":"Etanercept","level":3,"score":0.7413961887359619},{"id":"https://openalex.org/C3018125106","wikidata":"https://www.wikidata.org/wiki/Q432083","display_name":"Injection site","level":2,"score":0.6262379884719849},{"id":"https://openalex.org/C2779121184","wikidata":"https://www.wikidata.org/wiki/Q1166142","display_name":"Erythema","level":2,"score":0.6177794933319092},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.6006967425346375},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.5942144393920898},{"id":"https://openalex.org/C2776390293","wikidata":"https://www.wikidata.org/wiki/Q2035485","display_name":"Subcutaneous injection","level":2,"score":0.5595556497573853},{"id":"https://openalex.org/C2776291583","wikidata":"https://www.wikidata.org/wiki/Q432083","display_name":"Intramuscular injection","level":2,"score":0.4895575940608978},{"id":"https://openalex.org/C2780664588","wikidata":"https://www.wikidata.org/wiki/Q1878682","display_name":"Toxic epidermal necrolysis","level":2,"score":0.46020835638046265},{"id":"https://openalex.org/C2780564577","wikidata":"https://www.wikidata.org/wiki/Q179945","display_name":"Psoriasis","level":2,"score":0.45985347032546997},{"id":"https://openalex.org/C205679159","wikidata":"https://www.wikidata.org/wiki/Q3375179","display_name":"Transdermal","level":2,"score":0.4580380916595459},{"id":"https://openalex.org/C2776260265","wikidata":"https://www.wikidata.org/wiki/Q511097","display_name":"Psoriatic arthritis","level":3,"score":0.44354110956192017},{"id":"https://openalex.org/C2776093070","wikidata":"https://www.wikidata.org/wiki/Q621636","display_name":"Route of administration","level":2,"score":0.42942798137664795},{"id":"https://openalex.org/C17991360","wikidata":"https://www.wikidata.org/wiki/Q21173843","display_name":"Tumor necrosis factor alpha","level":2,"score":0.31262528896331787},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.290119469165802},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.2783728837966919},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.19787093997001648}],"mesh":[{"descriptor_ui":"D000068800","descriptor_name":"Etanercept","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003875","descriptor_name":"Drug Eruptions","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007074","descriptor_name":"Immunoglobulin G","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D007074","descriptor_name":"Immunoglobulin G","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D007074","descriptor_name":"Immunoglobulin G","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D007155","descriptor_name":"Immunologic Factors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D007155","descriptor_name":"Immunologic Factors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D007155","descriptor_name":"Immunologic Factors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D007279","descriptor_name":"Injections, Subcutaneous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009336","descriptor_name":"Necrosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010146","descriptor_name":"Pain","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D011565","descriptor_name":"Psoriasis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D013577","descriptor_name":"Syndrome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014409","descriptor_name":"Tumor Necrosis Factor-alpha","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D015535","descriptor_name":"Arthritis, Psoriatic","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D018124","descriptor_name":"Receptors, Tumor Necrosis Factor","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D018124","descriptor_name":"Receptors, Tumor Necrosis Factor","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.2165/1153426-s0-000000000-00000","doi":"https://doi.org/10.2165/1153426-s0-000000000-00000","is_oa":false,"landing_page_url":"https://doi.org/10.2165/1153426-s0-000000000-00000","pdf_url":null,"source":{"id":"https://openalex.org/S71020152","display_name":"American Journal of Clinical Dermatology","issn_l":"1175-0561","issn":["1175-0561","1179-1888"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Journal of Clinical Dermatology","raw_type":"journal-article"},{"id":"pmid:20586511","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20586511","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American journal of clinical dermatology","raw_type":"Case Reports"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/case-report","display_name":"Case Report"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":6,"referenced_works":["https://openalex.org/W1981383482","https://openalex.org/W2002802966","https://openalex.org/W2022342126","https://openalex.org/W2066825631","https://openalex.org/W2067206846","https://openalex.org/W2586732110"],"related_works":["https://openalex.org/W2520862309","https://openalex.org/W4405499013","https://openalex.org/W2530371936","https://openalex.org/W2057495387","https://openalex.org/W4393489749","https://openalex.org/W1968849222","https://openalex.org/W4404724016","https://openalex.org/W4401168613","https://openalex.org/W2766413966","https://openalex.org/W2566702220"],"abstract_inverted_index":null,"counts_by_year":[{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":4},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":8},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}